allogeneic stem cell transplantation in patients with hematological malignancies
Showing 1 - 25 of >10,000
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)
Not yet recruiting
- Hematological Malignancies
- Allogeneic T cell progenitors, cultured ex-vivo
- (no location specified)
Mar 2, 2023
Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)
Recruiting
- Haematological Malignancy
- 6 sessions of adapted physical activity after stem cell transplant
-
Nice, FranceCHU NICE, hopital ARCHET 1, hématologie
Jun 13, 2022
Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Nutritional Supplement Drink
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Hematological Malignancies Trial in Durham (fostamatinib)
Active, not recruiting
- Hematological Malignancies
-
Durham, North CarolinaDuke University of Medicine
Jul 14, 2022
Hematological Malignancies, CMV Infection Trial in Belgium (CMV-specific T cells, Standard anti-viral therapy)
Completed
- Hematological Malignancies
- CMV Infection
- CMV-specific T cells
- Standard anti-viral therapy
-
Gent, Oost-Vlaanderen, Belgium
- +7 more
Dec 19, 2022
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Leukemia, MDS Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- fludarabine phosphate
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Leukemia, MDS Trial (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- Myelodysplastic Syndromes
- busulfan
- +7 more
- (no location specified)
Feb 17, 2022
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
- Recipients
- Donors
-
Paris, FranceHopital Necker
Nov 19, 2021
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)
Recruiting
- Hematological Neoplasms
- Recurrence
- Peg interferon alfa-2b
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021
Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,
Terminated
- Related Donors Donating PBSC to a Family Member
- +4 more
- MGTA-145
- Plerixafor
-
Duarte, California
- +7 more
Apr 13, 2022
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with
Recruiting
- Acute Leukemia
- +27 more
- HSCT with TBI Regimen
- HSCT with Non-TBI Regimen
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Apr 12, 2022
Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Maywood, Durham
Completed
- Acute Lymphoblastic Leukemia (ALL)
- +4 more
-
Maywood, Illinois
- +1 more
Aug 1, 2021
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in
Not yet recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- Fludarabine
- +2 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023
Hematological Malignancy, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission Trial in New York (Cord blood
Completed
- Hematological Malignancy
- +5 more
- Cord blood stem cells
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 20, 2021
Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )
Recruiting
- Hematological Disease
- Allogeneic Hematopoietic Stem Cell Transplantation
- Hetrombopag
- placebo
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation
Completed
- Leukemia
- +2 more
- CliniMACS Fractionation system (Arm A)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2022
Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,
Recruiting
- Acute Erythroid Leukemia
- +10 more
- Fludarabine
- +5 more
-
San Francisco, California
- +5 more
Nov 1, 2022
Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell
Recruiting
- Hematologic Diseases
- COVID-19 vaccine(donor)
- COVID-19 vaccine(patient)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 8, 2022
Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Malignant Hematological Diseases
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Jul 3, 2023